Literature DB >> 24038756

Transcranial Doppler and brain MRI in children with sickle cell disease and high hemoglobin F levels.

Akram Asbeutah1, Renu Gupta, Osama Al-Saeid, Sam Ashebu, Sundus Al-Sharida, Ali Mullah-Ali, Nada Yousef Mustafa, Adekunle Adekile.   

Abstract

BACKGROUND/
OBJECTIVE: While overt stroke and silent brain infarcts (SBI) are uncommon among Kuwaiti patients with sickle cell disease (SCD), there have been no previous transcranial Doppler (TCD) studies in this population. The main objective of this study is to determine TCD velocities in a group of Kuwaiti children with SCD and correlate same with brain magnetic resonance imaging (MRI) and angiography (MRA) findings.
MATERIALS AND METHODS: Forty-three steady-state, pediatric patients with SCD aged 10.1 ± 3.9 years (21 SS, 19 Sβ(0)Thal, and 3 SD) were studied. Twenty-six age-matched, normal siblings of the patients served as controls. TCD was performed using a General Electric (GE), Vivid 3 equipment and MRI/MRA with a GE Signa Excite HD 1.5 Tesla magnet. Complete blood count was with an electronic counter and Hb quantitation with cation-exchange high performance liquid chromatography (HPLC).
RESULTS: The mean time-averaged mean of the maximum velocity (TAMV) was significantly higher in the SCD group than the controls, but was normal (<170 cm/second) in all. The mean values were comparable among the SS and Sβ(0)thal groups. Five (11.1%) patients had SBI and all were between 12 and 16 years of age. There was no significant difference of TAMV in this group compared to those without infarcts. No patient showed evidence of stenosis or any other abnormalities in the circle of Willis vessels.
CONCLUSION: The mild phenotype among Kuwaiti patients with SCD is reflected in normal TCD velocities and a low prevalence of SBI in children with the disease.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Kuwait Arabs; magnetic resonance imaging; sickle cell disease; silent brain infarcts; stroke; transcranial Doppler

Mesh:

Substances:

Year:  2013        PMID: 24038756     DOI: 10.1002/pbc.24758

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.

Authors:  Anwar Al-Awadhi; Adekunle Adekile; Rajaa Marouf
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis.

Authors:  Maite E Houwing; Rowena L Grohssteiner; Marjolein H G Dremmen; Ferdows Atiq; Wichor M Bramer; Anne P J de Pagter; C Michel Zwaan; Tonya J H White; Meike W Vernooij; Marjon H Cnossen
Journal:  BMC Med       Date:  2020-12-22       Impact factor: 8.775

Review 3.  The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.

Authors:  Adekunle Adekile
Journal:  Med Princ Pract       Date:  2020-09-04       Impact factor: 1.927

4.  Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study.

Authors:  Tamer Hassan; Mohamed Badr; Diana Hanna; Mohamed Arafa; Ahmed Elhewala; Sherief Dabour; Saad Shehata; Doaa Abdel Rahman
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.